It is difficult to define the optimal timing of the antiviral treatment in women infected with hepatitis C virus, who have child-bearing potential. Antiviral treatment is strictly contraindicated during the pregnancy and breast-feeding period. Data are conflicting about the question of treatment with modern drugs (peginterferon and ribavirin) before or after pregnancy. The risk of vertical transmission from mother to child is estimated about 5%. The mother’s viraemia seems to be the main transmission factor. There is a worse prognosis in nulliparous and postmenopausal women in the natural history of viral hepatitis C. Poor outcome in gestational age, maturity and Apgar score was not associated with hepatitis C virus infection. Combined antiviral treatment has frequent gynecological and other side-effects. The timing of the antiviral therapy in women in the child-bearing period is recommended individually.
Pár, A., Tornai, I., Szalay, F.: Experiences in antiviral treatment of chronic viral hepatitis B and C in Hungary (1998–2004). Orv. Hetil., 2007, 148 , 819–826.
Szalay F. , 'Experiences in antiviral treatment of chronic viral hepatitis B and C in Hungary (1998–2004) ' (2007 ) 148 Orv. Hetil. : 819 -826.
Codes, L., Asselah, T., Cazals-Hatem, D. et al.: Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy. Gut, 2007, 56 , 390–395.
Cazals-Hatem D. , 'Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy ' (2007 ) 56 Gut : 390 -395.
Di Martino, V., Lebray, P., Myers, R. P. et al.: Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen explosure. Hepatology, 2004, 40 , 1426–1433.
Myers R. P. , 'Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen explosure ' (2004 ) 40 Hepatology : 1426 -1433.
Plunkett, B. A., Grobman, W. A.: Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis. Am. J. Obstet. Gynecol., 2005, 192 , 1153–1161.
Grobman W. A. , 'Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis ' (2005 ) 192 Am. J. Obstet. Gynecol. : 1153 -1161.
Indolfi, G., Azzari, C., Moriondo, M. et al.: Alanine transaminase levels in the year before pregnancy predict the risk of hepatitis C virus vertical transmission. J. Med. Virol., 2006, 78 , 911–914.
Moriondo M. , 'Alanine transaminase levels in the year before pregnancy predict the risk of hepatitis C virus vertical transmission ' (2006 ) 78 J. Med. Virol. : 911 -914.
Ades, A. E., Parker, S., Walker, J. et al.: HCV prevalence in pregnant women in the UK. Epidemiol. Infect., 2000, 125 , 399–405.
Walker J. , 'HCV prevalence in pregnant women in the UK ' (2000 ) 125 Epidemiol. Infect. : 399 -405.
Hutchinson, S. J., Goldberg, D. J., King, M. et al.: Hepatitis C virus among childbearing women in Scotland: prevalence, deprivation and diagnosis. Gut, 2004, 53 , 593–598.
King M. , 'Hepatitis C virus among childbearing women in Scotland: prevalence, deprivation and diagnosis ' (2004 ) 53 Gut : 593 -598.
Ferrero, S., Lungaro, P., Bruzzone, B. M. et al.: Prospective study of mother-to-infant transmission of hepatitis C virus: a 10-year survey (1990–2000). Acta Obstet. Gynecol. Scand., 2003, 82 , 229–234.
Bruzzone B. M. , 'Prospective study of mother-to-infant transmission of hepatitis C virus: a 10-year survey (1990–2000) ' (2003 ) 82 Acta Obstet. Gynecol. Scand. : 229 -234.
Jaffery, T., Tariq, N., Ayub, R., Yawar, A.: Frequency of hepatitis C in pregnancy and pregnancy outcome. J Coll. Physicians Surg. Pak., 2005, 15 , 716–719.
Yawar A. , 'Frequency of hepatitis C in pregnancy and pregnancy outcome ' (2005 ) 15 J Coll. Physicians Surg. Pak. : 716 -719.
Newell, M. L., Pembrey, L.: Mother-to-child transmission of hepatitis C virus infection. Drugs Today (Barc)., 2002, 38 , 321–337.
Pembrey L. , 'Mother-to-child transmission of hepatitis C virus infection ' (2002 ) 38 Drugs Today (Barc). : 321 -337.
Njouom, R., Pasquier, C., Ayouba, A. et al.: Low risk of mother-to-child transmission of hepatitis C virus in Yaounde, Cameroon: the ANRS 1262 study. Am. J. Trop. Med. Hyg., 2005, 73 , 460–466.
Ayouba A. , 'Low risk of mother-to-child transmission of hepatitis C virus in Yaounde, Cameroon: the ANRS 1262 study ' (2005 ) 73 Am. J. Trop. Med. Hyg. : 460 -466.
Xiong, S. K., Okajima, Y., Ishikawa, K. et al.: Vertical transmission of hepatitis C virus: risk factors and infantile prognosis. J. Obstet. Gynecol. Res., 1998, 24 , 57–61.
Ishikawa K. , 'Vertical transmission of hepatitis C virus: risk factors and infantile prognosis ' (1998 ) 24 J. Obstet. Gynecol. Res. : 57 -61.
Syriopoulou, V., Nikopoulou, G., Daikos, G. L. et al.: Mother to child transmission of hepatitis C virus: rate of infection and risk factors. Scand. J. Infect. Dis., 2005, 37 , 350–353.
Daikos G. L. , 'Mother to child transmission of hepatitis C virus: rate of infection and risk factors ' (2005 ) 37 Scand. J. Infect. Dis. : 350 -353.
Mast, E. E., Hwang, L. Y., Seto, D. S. et al.: Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J. Infect. Dis., 2005, 192 , 1880–1889.
Seto D. S. , 'Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy ' (2005 ) 192 J. Infect. Dis. : 1880 -1889.
Polywka, S., Pembrey, L., Tovo, P. A., Newell, M. L.: Accuracy of HCV-RNA PCR tests for diagnosis or exclusion of vertically acquired HCV infection. J. Med. Virol., 2006, 78 , 305–310.
Newell M. L. , 'Accuracy of HCV-RNA PCR tests for diagnosis or exclusion of vertically acquired HCV infection ' (2006 ) 78 J. Med. Virol. : 305 -310.
Slowik, M. K., Jhaveri, R.: Hepatitis B and C viruses in infants and young children. Semin. Pediatr. Infect. Dis., 2005, 16 , 296–305.
Jhaveri R. , 'Hepatitis B and C viruses in infants and young children ' (2005 ) 16 Semin. Pediatr. Infect. Dis. : 296 -305.
Inui, A., Fujisawa, T., Sogo, T. et al.: Different outcomes of vertical transmission of hepatitis C virus in a twin pregnancy. J. Gastroenterol.; Hepatol., 2002, 17 , 617–619.
Sogo T. , 'Different outcomes of vertical transmission of hepatitis C virus in a twin pregnancy ' (2002 ) 17 J. Gastroenterol.; Hepatol. : 617 -619.
Boxall, E., Baumann, K., Price, N. et al.: Discordant outcome of perinatal transmission of hepatitis C in twin pregnancies. J. Clin. Virol., 2007, 38 , 91–95.
Price N. , 'Discordant outcome of perinatal transmission of hepatitis C in twin pregnancies ' (2007 ) 38 J. Clin. Virol. : 91 -95.
Zuccotti, G. V., Salvini, F., Farina, F. et al.: Longitudinal long-term follow-up study of children with vertically acquired hepatitis C virus infection. J. Int. Med. Res., 2006, 34 , 215–222.
Farina F. , 'Longitudinal long-term follow-up study of children with vertically acquired hepatitis C virus infection ' (2006 ) 34 J. Int. Med. Res. : 215 -222.
Batallan, A., Faucher, P., Poncelet, C. et al.: Mother-to-child transmission of hepatitis C virus: recent news about the benefit of the caesarean sections. Gynecol. Obstet. Fertil., 2003, 31 , 964–968.
Poncelet C. , 'Mother-to-child transmission of hepatitis C virus: recent news about the benefit of the caesarean sections ' (2003 ) 31 Gynecol. Obstet. Fertil. : 964 -968.
European Paediatric Hepatitis C Virus Network: A significant sex – but not elective cesarean section – effect on mother-to-child transmission of hepatitis C virus infection. J. Infect. Dis., 2005, 192 , 1872–1879.
'A significant sex – but not elective cesarean section – effect on mother-to-child transmission of hepatitis C virus infection ' (2005 ) 192 J. Infect. Dis. : 1872 -1879.
McIntyre, P. G., Tosh, K., McGuire, W.: Caesarean section versus vaginal delivery for preventing mother to infant hepatitis C virus transmission. Cochrane Database Syst. Rev. 2006, (4): CD005546. Review.
Langlet, P., Lasser, L., Sidi, B.: [Hepatitis C in women planning a pregnancy: current opinions]. Rev. Med. Brux., 2005, 26 , 487–491.
Sidi B. , '[Hepatitis C in women planning a pregnancy: current opinions] ' (2005 ) 26 Rev. Med. Brux. : 487 -491.
Pembrey, L., Newell, M. L., Tovo, P. A., EPHN Collaborators: The management of HCV infected pregnant women and their children. European Pediatric HCV network. J. Hepatol., 2005, 43 , 515–525.
Tovo P. A. , 'The management of HCV infected pregnant women and their children. European Pediatric HCV network ' (2005 ) 43 J. Hepatol. : 515 -525.
Hattori, Y., Orito, E., Ohno, T. et al.: Loss of hepatitis C virus RNA after parturition in female patients with chronic HCV infection. J. Med. Virol., 2003, 71 , 205–211.
Ohno T. , 'Loss of hepatitis C virus RNA after parturition in female patients with chronic HCV infection ' (2003 ) 71 J. Med. Virol. : 205 -211.
Lin, H. H., Kao, J. H.: Hepatitis C virus load during pregnancy and puerperium. BJOG, 2000, 107 , 1503–1506.
Kao J. H. , 'Hepatitis C virus load during pregnancy and puerperium ' (2000 ) 107 BJOG : 1503 -1506.
Pirwany, I. R., Phillips, S., Kelly, S. et al.: Reproductive performance of couples discordant for hepatitis B and C following IVF treatment. J. Assist. Reprod. Genet., 2004, 21 , 157–161.
Kelly S. , 'Reproductive performance of couples discordant for hepatitis B and C following IVF treatment ' (2004 ) 21 J. Assist. Reprod. Genet. : 157 -161.
Kilham, L., Ferm, V. H.: Congenital anomalies induced in hamster embryos with ribavirin. Science, 1977, 195 , 413–414.
Ferm V. H. , 'Congenital anomalies induced in hamster embryos with ribavirin ' (1977 ) 195 Science : 413 -414.
Ferm, V. H., Willhite, C., Kilham, L.: Teratogenic effects of ribavirin on hamster and rat embryos. Teratology, 1978, 17 , 93–101.
Kilham L. , 'Teratogenic effects of ribavirin on hamster and rat embryos ' (1978 ) 17 Teratology : 93 -101.
Taguchi, N., Ito, S.: Paternal use of ribavirin-interferon alpha 2b combination therapy before conception. Can. Fam. Physician, 2005, 51 , 1623–1625.
Ito S. , 'Paternal use of ribavirin-interferon alpha 2b combination therapy before conception ' (2005 ) 51 Can. Fam. Physician : 1623 -1625.
Hegenbarth, K., Maurer, U., Kroisel, P. M. et al.: No evidence for mutagenic effects of ribavirin: report of two normal pregnancies. Am. J. Gastroenterol., 2001, 96 , 2286–2287.
Kroisel P. M. , 'No evidence for mutagenic effects of ribavirin: report of two normal pregnancies ' (2001 ) 96 Am. J. Gastroenterol. : 2286 -2287.
Labarga, P., Pinilla, J., Cachorro, I. et al.: Infant of 22 months of age with no anomalies born from a HCV- and HIV infected mother under treatment with pegylated interferon, ribavirin and antiretroviral therapy during the first 16 weeks of pregnancy. Reprod. Toxicol., 2007, 24 , 414–416.
Cachorro I. , 'Infant of 22 months of age with no anomalies born from a HCV- and HIV infected mother under treatment with pegylated interferon, ribavirin and antiretroviral therapy during the first 16 weeks of pregnancy ' (2007 ) 24 Reprod. Toxicol. : 414 -416.
Banwell, C., Bammer, G., Main, N. et al.: Disturbingly low levels of contraception among women living with hepatitis C. Aust. N. Z. J. Public Health., 2003, 27 , 620–626.
Main N. , 'Disturbingly low levels of contraception among women living with hepatitis C ' (2003 ) 27 Aust. N. Z. J. Public Health. : 620 -626.
Alric, L., Costedoat, N., Piette, J. C. et al.: Hepatitis C and pregnancy. Rev. Med. Interne, 2002, 23 , 283–291.
Piette J. C. , 'Hepatitis C and pregnancy ' (2002 ) 23 Rev. Med. Interne : 283 -291.
Dal Molin, G., D’Agaro, P., Ansaldi, F. et al.: Mother-to-infant transmission of hepatitis C virus: rate of infection and assessment of viral load and IgM anti HCV as risk factors. J. Med. Virol., 2002, 67 , 137–142.
Ansaldi F. , 'Mother-to-infant transmission of hepatitis C virus: rate of infection and assessment of viral load and IgM anti HCV as risk factors ' (2002 ) 67 J. Med. Virol. : 137 -142.
Zucotti, G. V., Cucchi, C., Torcoletti, M. et al.: Proposal of a step-wise follow-up for hepatitis C seropositive mothers and their infants. Pediatr. Med. Chir., 2003, 25 , 6–11.
Torcoletti M. , 'Proposal of a step-wise follow-up for hepatitis C seropositive mothers and their infants ' (2003 ) 25 Pediatr. Med. Chir. : 6 -11.
Impact of maternal HIV coinfection on the vertical transmission of hepatitis C virus: a meta-analysis. Clin. Infect. Dis., 2007, 44, 1123–1131.
Peixoto, M. F., Mattos, A. A., Remiao, J. O. et al.: Vertical transmission of hepatitis C in a hospital of southern Brasil. Arq. Gastroenterol., 2004, 41 , 84–87.
Remiao J. O. , 'Vertical transmission of hepatitis C in a hospital of southern Brasil ' (2004 ) 41 Arq. Gastroenterol. : 84 -87.
Saez, A., Losa, M., Lo Iacono, O. et al.: Diagnostic and prognostic value of virologic tests in vertical transmission of hepatitis C virus infection: results of a large prospective study in pregnant women. Hepatogastroenterology, 2004, 51 , 1104–1108.
Iacono O. , 'Diagnostic and prognostic value of virologic tests in vertical transmission of hepatitis C virus infection: results of a large prospective study in pregnant women ' (2004 ) 51 Hepatogastroenterology : 1104 -1108.
Serme, A. K., Ilboudo, P. D., Samandoulgou, A. et al.: [Prevalence of Hepatitis C virus infection in pregnant women and mother-child transmission in Ouagadougou, Burkina Faso]. Bull. Soc. Pathol. Exot., 2006, 99 , 108–109.
Samandoulgou A. , '[Prevalence of Hepatitis C virus infection in pregnant women and mother-child transmission in Ouagadougou, Burkina Faso] ' (2006 ) 99 Bull. Soc. Pathol. Exot. : 108 -109.
Shoboksi, O. A., Serebour, F. E., Al-Drees, A. Z. et al.: Hepatitis C virus seroprevalence rate among Saudis. Saudi Med. J., 2003, 24, Suppl. 2. , 81–86.
Al-Drees A. Z. , 'Hepatitis C virus seroprevalence rate among Saudis ' (2003 ) 24 Saudi Med. J. : 81 -86.
Stoszek, S. K., Abdel-Hamid, M., Narooz, S. et al.: Prevalence of and risk factors for hepatitis C in rural pregnant Egyptian women. Trans. R. Soc. Trop. Med. Hyg., 2006, 100 , 102–107.
Narooz S. , 'Prevalence of and risk factors for hepatitis C in rural pregnant Egyptian women ' (2006 ) 100 Trans. R. Soc. Trop. Med. Hyg. : 102 -107.
Tajiri, H., Miyoshi, Y., Funada, S. et al.: Prospective study of mother-to-infant transmission of hepatitis C virus. Pediatr. Infect. Dis. J., 2001, 20 , 10–14.
Funada S. , 'Prospective study of mother-to-infant transmission of hepatitis C virus ' (2001 ) 20 Pediatr. Infect. Dis. J. : 10 -14.